What Has Been The Evolution of the Gastroretentive Drug Delivery Systems Outsourcing Market in Recent Years?
The gastroretentive drug delivery systems outsourcing market has seen considerable growth due to a variety of factors.
• The gastroretentive drug delivery systems outsourcing market has experienced strong growth in recent years. It will grow from $1.39 billion in 2024 to $1.5 billion in 2025, at a compound annual growth rate (CAGR) of 8.3%.
This growth is attributed to the increasing incidence of stomach and small intestine disorders, the rise of drug delivery systems, growing gastric cancer prevalence, government initiatives, and more hospitals entering the sector.
What Is the Forecasted Market Size and Growth Rate for The Gastroretentive Drug Delivery Systems Outsourcing Market Size In The Coming Years?
The gastroretentive drug delivery systems outsourcing market is expected to maintain its strong growth trajectory in upcoming years.
• The gastroretentive drug delivery systems outsourcing market is expected to grow to $2.03 billion by 2029, at a CAGR of 7.9%.
Growth will be attributed to the increase in ambulatory centers, a focus on patient compliance, rising chronic disease rates, the adoption of personalized medicine, and the aging population. Key trends will include advancements in polymer science, novel drug release modifiers, the integration of digital health technologies, and the development of smart gastroretentive systems.
What Factors Are Driving Growth In The Gastroretentive Drug Delivery Systems Outsourcing Market?
The increasing prevalence of gastrointestinal disorders is expected to drive the growth of the gastroretentive drug delivery systems outsourcing market. Gastrointestinal disorders are on the rise due to factors such as aging, medication use, and lifestyle changes. Outsourcing these systems helps pharmaceutical companies address this growing issue, improving patient outcomes. For example, the American Cancer Society reported a 3.18% rise in gastrointestinal cancer cases in the U.S. between 2021 and 2022. This growing prevalence is driving the market for gastroretentive drug delivery system outsourcing.
What Are The Main Segments Of The Global Gastroretentive Drug Delivery Systems Outsourcing Market?
The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –
1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users
Subsegments:
1) Floating Systems: Single Unit Systems, Multiple Unit Systems
2) Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers
3) Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems
Pre-Book The Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Gastroretentive Drug Delivery Systems Outsourcing Market?
Companies in the gastroretentive drug delivery systems outsourcing market are launching innovative products like ready-to-fill colon functional capsules to improve drug delivery efficiency. For example, in September 2024, Evonik launched the EUDRACAP colon functional capsules, designed for targeted oral drug delivery to the ileo-colonic region. These capsules are pre-manufactured, simplifying drug development and accelerating time-to-market.
Who Are the Key Players In The Gastroretentive Drug Delivery Systems Outsourcing Market?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are:
• Pfizer Inc.
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• AbbVie Inc.
• Sanofi S.A.
• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc
• Evonik Industries AG
• Alcon Inc.
• SGS SA
• Lonza Group AG
• FMC Corporation
• Sun Pharmaceutical Industries Ltd.
• Catalent Inc.
• AptarGroup Inc.
• Cadila Pharmaceuticals
• Ashland Global Holdings Inc.
• Lupin Limited
• Torrent Pharmaceuticals Ltd.
• Evotec SE
• Colorcon Inc.
• Ranbaxy Laboratories Limited
• Quotient Sciences Limited
• Aenova Group
• Vectura Group Ltd.
• Assertio Therapeutics Inc.
• Coating Place Inc.
• Xiromed LLC
• SPI Pharma Inc.
What Is The Most Dominant Region In The Gastroretentive Drug Delivery Systems Outsourcing Market?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
